| dc.contributor.author | Marino, S | |
| dc.contributor.author | Badodi, S | |
| dc.date.accessioned | 2021-04-21T15:26:58Z | |
| dc.date.available | 2021-03-12 | |
| dc.date.available | 2021-04-21T15:26:58Z | |
| dc.date.issued | 2021-04-12 | |
| dc.identifier.citation | Badodi, S., Pomella, N., Zhang, X. et al. Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. Nat Commun 12, 2148 (2021). https://doi.org/10.1038/s41467-021-22379-7 | en_US |
| dc.identifier.issn | 2041-1723 | |
| dc.identifier.other | 2148 | |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/71421 | |
| dc.description.abstract | Deregulation of chromatin modifiers plays an essential role in the pathogenesis of
medulloblastoma, the most common paediatric malignant brain tumour. Here, we identify a
BMI1-dependent sensitivity to deregulation of inositol metabolism in a proportion of
medulloblastoma. We demonstrate mTOR pathway activation and metabolic adaptation
specifically in medulloblastoma of the molecular subgroup G4 characterised by a BMI1High;
CHD7Low signature and show this can be counteracted by IP6 treatment. Finally, we
demonstrate that IP6 synergises with cisplatin to enhance its cytotoxicity in vitro and extends
survival in a pre-clinical BMI1High;CHD7Low xenograft model. | en_US |
| dc.publisher | Nature Research (part of Springer Nature) | en_US |
| dc.relation.ispartof | Nature Communications | |
| dc.rights | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/. | |
| dc.title | Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. | en_US |
| dc.type | Article | en_US |
| dc.rights.holder | © The Author(s) 2021 | |
| dc.identifier.doi | 10.1038/s41467-021-22379-7 | |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Accepted | en_US |
| pubs.publisher-url | https://doi.org/10.1038/s41467-021-22379-7 | |
| pubs.volume | 12 | |
| dcterms.dateAccepted | 2021-03-12 | |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
